(Total Views: 282)
Posted On: 03/16/2021 1:44:02 PM
Post# of 36541
Re: OrlandoJohn #27587
It's about time we hear something from Generex / NGIO on the listing and the deals.
They have no problem going on these interviews and giving tidbits without really discussing the deals and how the successful test results affect the deals 'right now'. Joe said on here, that yes, they are still doing the deals, but that doesn't say a thing about what they are doing now, while they are working on the IND or what they will be doing while the FDA looks at it. Will the deals sit and wait until the FDA gives the go ahead or are they moving ahead with everything while the IND is being worked on, etc..? That is a huge question to be answered because over in China, that represents 1.5 billion dollars in revenue outside of the USA and impacts other deals as well.
Then there is the uplist. What is going on with it?
These are the things we need to know.
They have no problem going on these interviews and giving tidbits without really discussing the deals and how the successful test results affect the deals 'right now'. Joe said on here, that yes, they are still doing the deals, but that doesn't say a thing about what they are doing now, while they are working on the IND or what they will be doing while the FDA looks at it. Will the deals sit and wait until the FDA gives the go ahead or are they moving ahead with everything while the IND is being worked on, etc..? That is a huge question to be answered because over in China, that represents 1.5 billion dollars in revenue outside of the USA and impacts other deals as well.
Then there is the uplist. What is going on with it?
These are the things we need to know.
(2)
(0)Scroll down for more posts ▼
